139 related articles for article (PubMed ID: 20406102)
1. Cytochrome P4502E1 (CYP2E1) genetic polymorphisms in a Lebanese population: frequency distribution and association with morbid diseases.
Zgheib NK; Mitri Z; Geryess E; Noutsi P
Genet Test Mol Biomarkers; 2010 Jun; 14(3):393-7. PubMed ID: 20406102
[TBL] [Abstract][Full Text] [Related]
2. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population.
Ulusoy G; Arinç E; Adali O
Arch Toxicol; 2007 Oct; 81(10):711-8. PubMed ID: 17380320
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of CYP2E1 and GSTM1 in a Thai population.
Sangrajrang S; Jedpiyawongse A; Srivatanakul P
Asian Pac J Cancer Prev; 2006; 7(3):415-9. PubMed ID: 17059334
[TBL] [Abstract][Full Text] [Related]
4. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.
Feng J; Pan X; Yu J; Chen Z; Xu H; El-Rifai W; Zhang G; Xu Z
PLoS One; 2012; 7(9):e44478. PubMed ID: 22957075
[TBL] [Abstract][Full Text] [Related]
5. [Association analysis of gene polymorphism in alcohol metabolizing enzymes with risk for coronary atherosclerosis].
Marusin AV; Stepanov VA; Spiridonova MG; Khar'kov VA; Pel's IaR; Puzyrev VP
Genetika; 2007 Mar; 43(3):409-16. PubMed ID: 17486761
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms in workers exposed to benzene].
Chen Z; Ling J; Liu Y; Wu X; Wang D; Wang J; Tu H
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Aug; 33(8):595-7. PubMed ID: 26653810
[TBL] [Abstract][Full Text] [Related]
7. The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies.
Tang K; Li Y; Zhang Z; Gu Y; Xiong Y; Feng G; He L; Qin S
BMC Cancer; 2010 Oct; 10():575. PubMed ID: 20969746
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.
Liu S; Park JY; Schantz SP; Stern JC; Lazarus P
Oral Oncol; 2001 Jul; 37(5):437-45. PubMed ID: 11377232
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.
Kato S; Shields PG; Caporaso NE; Sugimura H; Trivers GE; Tucker MA; Trump BF; Weston A; Harris CC
Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):515-8. PubMed ID: 8000304
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women.
Zgheib NK; Shamseddine AA; Geryess E; Tfayli A; Bazarbachi A; Salem Z; Shamseddine A; Taher A; El-Saghir NS
Mutat Res; 2013; 747-748():40-7. PubMed ID: 23628324
[TBL] [Abstract][Full Text] [Related]
11. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.
Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J
Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018
[TBL] [Abstract][Full Text] [Related]
12. The frequency of cytochrome P450 2E1 polymorphisms in Black South Africans.
Chelule PK; Pegoraro RJ; Gqaleni N; Dutton MF
Dis Markers; 2006; 22(5-6):351-4. PubMed ID: 17264406
[TBL] [Abstract][Full Text] [Related]
13. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.
Zhou GW; Hu J; Li Q
World J Gastroenterol; 2010 Jun; 16(23):2949-53. PubMed ID: 20556843
[TBL] [Abstract][Full Text] [Related]
14. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations.
Farker K; Lehmann MH; Kästner R; Hoffmann A; Janitzky V; Schubert J; Matz U; Hofmann W
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):463-8. PubMed ID: 9760005
[TBL] [Abstract][Full Text] [Related]
15. Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis.
Bose PD; Sarma MP; Medhi S; Das BC; Husain SA; Kar P
J Gastroenterol Hepatol; 2011 Feb; 26(2):312-8. PubMed ID: 21261721
[TBL] [Abstract][Full Text] [Related]
16. Significant genotype difference in the CYP2E1 PstI polymorphism of indigenous groups in Sabah, Malaysia with Asian and non-Asian populations.
Goh LP; Chong ET; Chua KH; Chuah JA; Lee PC
Asian Pac J Cancer Prev; 2014; 15(17):7377-81. PubMed ID: 25227845
[TBL] [Abstract][Full Text] [Related]
17. Frequency distribution of high risk alleles of CYP2C19, CYP2E1, CYP3A4 genes in Haryana population.
Gulati S; Yadav A; Kumar N; Kanupriya ; Kumar G; Aggarwal N; Gupta R
Environ Toxicol Pharmacol; 2014 May; 37(3):1186-93. PubMed ID: 24814262
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Cooper J; Carpenter CL; Navidi WC; Ding L; Idle JR
Pharmacogenetics; 1996 Apr; 6(2):151-8. PubMed ID: 9156693
[TBL] [Abstract][Full Text] [Related]
19. Significance of genetic polymorphisms at multiple loci of CYP2E1 in the risk of development of childhood acute lymphoblastic leukemia.
Ulusoy G; Adali O; Tumer TB; Sahin G; Gozdasoglu S; Arinç E
Oncology; 2007; 72(1-2):125-31. PubMed ID: 18025800
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population.
Krishnakumar D; Gurusamy U; Dhandapani K; Surendiran A; Baghel R; Kukreti R; Gangadhar R; Prayaga U; Manjunath S; Adithan C
Fundam Clin Pharmacol; 2012 Apr; 26(2):295-306. PubMed ID: 21265876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
